Evidence map›Paper›PMID 42653953›Full record

ArticleMolecules (Basel, Switzerland)2026

Spectroscopic Insights into Lysozyme Structural Modulation by Polyphenols: A Combined FTIR and VCD Study.

Karolina Musiał, Katarzyna Cieślik-Boczula

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karolina MusiałFaculty of Chemistry, University of Wrocław, Joliot-Curie 14, 50-383 Wrocław, Poland.ORCID 0000-0002-3977-6194
Katarzyna Cieślik-BoczulaFaculty of Chemistry, University of Wrocław, Joliot-Curie 14, 50-383 Wrocław, Poland.

Funding

National Science Centre 2021/43/B/NZ9/00345
6 · The paper itself

Abstract

Protein fibril formation is of considerable interest due to the association of fibrils with many neurodegenerative diseases as well as non-neuropathic amyloidosis. In this study, the effects of individual phenolic compounds and their mixtures-including caffeic acid (CC), quercetin (Que), and resveratrol (Res)-on the fibrillation of lysozyme (Lys) were investigated using Fourier transform infrared (FTIR) and vibrational circular dichroism (VCD) spectroscopy. These phenolic compounds are known as potent modulators, particularly inhibitors, of fibrillation in various proteins and peptides. While their anti-fibrillar activity has been extensively studied via the Thioflavin T (ThT) fluorescence assay, here FTIR and VCD spectroscopy are employed for a comprehensive, label-free investigation of their effects. The results indicate that CC, Que, and Res influence Lys fibrillogenesis in ways that depend on the phenol concentration, their combination (mixing ratios), and the experimental conditions. In particular, Lys was observed to form left-handed fibrils under these conditions in the presence of these phenolic compounds, as evidenced by the VCD signal. Furthermore, a comparison was made of the inhibitory effects of the individual phenols and their mixtures on Lys fibril formation: CC and Res were more effective inhibitors than Que. Interestingly, an equimolar mixture of CC and Res exhibited a strong synergistic inhibitory effect on fibrillation, whereas the combination of CC with Que showed an antagonistic effect. Overall, this study provides deeper insights into how specific polyphenolic compounds influence protein fibrillation processes, offering valuable information for developing therapeutic interventions targeting protein aggregation-associated disorders.

Indexed as

MuramidasePolyphenolsAnimalsCaffeic AcidsCircular DichroismQuercetinResveratrolSpectroscopy, Fourier Transform Infraredcaffeic acidCaffeic AcidsMuramidasePolyphenolsQuercetinResveratrolantagonistic effectcaffeic acidquercetinresveratrolsynergistic effectVCD spectroscopy

Identifiers

PMID42653953
PMCPMC13515142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.